Published in Int J Microcirc Clin Exp on September 20, 1996
[Capillaroscopy. Procedure and nomenclature]. Z Rheumatol (2010) 1.06
Capillaroscopy: questions and answers. Clin Rheumatol (2007) 0.84
Nailfold videocapillaroscopy in patients with systemic lupus erythematosus. Rheumatol Int (2005) 0.78
[Gender-specific differences in capillaroscopy in healthy persons and patients with inflammatory rheumatic diseases]. Z Rheumatol (2014) 0.75
A proteomic view on genome-based signal peptide predictions. Genome Res (2001) 3.96
Increasing patient involvement in choosing treatment for early breast cancer. Cancer (1995) 3.24
Patient participation in deciding breast cancer treatment and subsequent quality of life. Med Decis Making (1997) 3.14
Transcription of the Arabidopsis CPD gene, encoding a steroidogenic cytochrome P450, is negatively controlled by brassinosteroids. Plant J (1998) 2.57
The binding of nicotinamide-adenine dinucleotide to yeast d-glyceraldehyde-3-phosphate dehydrogenase: temperature-jump relaxation studies on the mechanism of an allosteric enzyme. Proc Natl Acad Sci U S A (1966) 2.26
Single-chamber versus dual-chamber implantable cardioverter defibrillators: indications and clinical results. Am J Cardiol (1999) 1.44
[Acute poisoning with strychnine-N-oxide hydrochloride (Movellan tablets) and treatment with diazepam]. Arch Toxikol (1969) 1.17
Inactivation of brassinosteroid biological activity by a salicylate-inducible steroid sulfotransferase from Brassica napus. J Biol Chem (1999) 1.11
Limits on neutrino emission from gamma-ray bursts with the 40 string IceCube detector. Phys Rev Lett (2011) 1.08
Guidelines for testing drugs for chronic venous insufficiency. Vasa (2000) 1.00
Novel quantitative trait loci for blood pressure and related traits on rat chromosomes 1, 10, and 18. Biochem Biophys Res Commun (1997) 0.88
[Purity criteria for the crystallizable isoenzyme of D-glyceraldehyde-3-phosphate dehydrogenase from baker's yeast]. Hoppe Seylers Z Physiol Chem (1968) 0.88
Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy. Fertil Steril (1995) 0.86
Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study. Angiology (1984) 0.85
Cyclic amides of N alpha-arylsulfonylaminoacylated 4-amidinophenylalanine--tight binding inhibitors of thrombin. Thromb Res (1983) 0.85
Colour coded duplex sonography in ischemic finger artery disease--a comparison with hand arteriography. Vasa (1997) 0.84
Frequency of malignant diseases in deep venous thrombosis of the lower extremities. Int Angiol (1991) 0.83
Diabetic nephropathy but not HbA1c is predictive for frequent complications of Charcot feet - long-term follow-up of 164 consecutive patients with 195 acute Charcot feet. Exp Clin Endocrinol Diabetes (2012) 0.83
Long-term follow-up of thromboangiitis obliterans. Vasa (1998) 0.82
Nonlinear polarization spectroscopy in the frequency domain of light-harvesting complex II: absorption band substructure and exciton dynamics. Biophys J (1995) 0.80
Prostaglandin E1 infusion therapy in dry age-related macular degeneration. Prostaglandins Leukot Essent Fatty Acids (2005) 0.80
[Effect of Pentoxyphylline on blood viscosity and erythrocyte surface]. Med Welt (1975) 0.80
Randomized reliability study evaluating constant-load and graded-exercise treadmill test for intermittent claudication. Angiology (1999) 0.79
[Bilateral thrombosis of the popliteal vein with diffuse muscular necrosis following CO intoxication]. Dtsch Med Wochenschr (1969) 0.79
Inhibition of bovine and human thrombins by derivatives of benzamidine. Thromb Res (1984) 0.79
Complete ulcer healing as primary endpoint in studies on critical limb ischemia? A critical reappraisal. Eur J Vasc Endovasc Surg (2006) 0.79
Congenic strain confirms putative quantitative trait locus for body weight in the rat. Mamm Genome (1998) 0.79
[Psychiatric and psychometric examinations in Raynaud's syndrome (author's transl)]. Dtsch Med Wochenschr (1978) 0.79
Comparison of genetic variability at microsatellite loci in wild rats and inbred rat strains (Rattus norvegicus). Mamm Genome (1997) 0.78
Effects of sodium etidronate in combination with low-dose norethindrone in patients administered a long-acting GnRH agonist: a preliminary report. Obstet Gynecol (1993) 0.78
Excitation trap approach to analyze size and pigment-pigment coupling: reconstitution of LH1 antenna of Rhodobacter sphaeroides with Ni-substituted bacteriochlorophyll. Biochemistry (2001) 0.78
Limits on a muon flux from neutralino annihilations in the sun with the IceCube 22-string detector. Phys Rev Lett (2009) 0.78
[Leiomyosarcoma in the area of the pelvic vein]. Vasa (1993) 0.78
Hemostatic and fibrinolytic effects of systemic prostaglandin E1 therapy in patients with peripheral arterial disease. Vasa (2003) 0.78
An integrated rat genome map based on genetic and cytogenetic data. Exp Anim (2000) 0.78
[Synthetic inhibitors of serine proteinases. 8. Inhibition of trypsin, plasmin and thrombin by means of amidinophenyl-derivatives with ketonic-structure]. Pharmazie (1976) 0.78
[Color-coded duplex ultrasound of lower leg arteries--image reliability with reference to Fontaine stages]. Ultraschall Med (1993) 0.78
Symptomatology of the subclavian steal syndrome. Angiology (1969) 0.77
[Doppler ultrasound studies of the extracranial cerebral vessels in migraine patients after ergotamine tartrate administration]. Dtsch Med Wochenschr (1983) 0.77
[Effects of actihaemyl on the arteriovenous oxygen difference and the cardiac output]. Z Kreislaufforsch (1972) 0.77
Chromosomal mapping of genes for epilepsy in NER: a rat strain with tonic-clonic seizures. Epilepsia (2000) 0.77
Circulating nerve growth factor in primary and secondary Raynaud's syndrome - results of a pilot study. Vasa (2009) 0.76
WOK.1W rats. A potential animal model of the insulin resistance syndrome. Ann N Y Acad Sci (1997) 0.76
Diabetes and hypertension in rodent models. Ann N Y Acad Sci (1997) 0.76
[Effect of isoxsuprine on blood viscosity]. Vasa (1976) 0.76
Vital capillary microscopic findings in the nailfold of patients with diabetes mellitus. Vasa (2000) 0.76
In vivo capillary microscopy findings and ophthalmoscopy findings in scleroderma. Arthritis Rheum (1987) 0.76
[X-ray diagnosis of the subclavian steal syndrome]. Radiologe (1967) 0.75
[Rheographic studies on the hemodynamics of retrograde vertebral artery perfusion in a subclavian steal syndrome associated with aortic coarctation]. Z Kreislaufforsch (1968) 0.75
Incidence of thrombophlebitis with naftidrofuryl. Br Med J (1978) 0.75
In-vivo capillary-microscopical findings in patients with thrombangiitis obliterans, progressive systemic scleroderma, and rheumatoid arthritis, respectively. Klin Wochenschr (1986) 0.75
Low-intensity two-step absorption of chlorophyll A in vivo. Biophys J (1978) 0.75
[Subclavian steal syndrome]. Arch Kreislaufforsch (1968) 0.75
[Incidence of malignant disease in acute phlebothrombosis]. Vasa Suppl (1987) 0.75
[Mucoid cystic adventitial degeneration of the popliteal artery with simultaneous arteriosclerosis]. Vasa (1990) 0.75
[Laser Doppler flowmetry in probands with healthy vessels and in patients with Fontaine stage II-IV peripheral arterial occlusive disease]. Vasa Suppl (1987) 0.75
[15 years Amputierten-Initiative e.V]. Vasa (2009) 0.75
Treadmill testing for evaluation of claudication: comparison of constant-load and graded-exercise tests. Eur J Vasc Endovasc Surg (1997) 0.75
Contrast enhancement in leg vessels. Clin Radiol (1996) 0.75
[Synthetic inhibitors of serine proteinases. 10. The inhibition of trypsin, plasmin and thrombin by 4-amidinophenylaralkanone]. Pharmazie (1976) 0.75
[Synthesis of 1-phenyl-2-[4-amidinophenyl](2)-ethanol- and of 1-aryl-4-[4-amidinophenyl]-(1)-propanols]. Pharmazie (1978) 0.75
[Contact plate thermography with cold provocation tests for the diagnosis of Raynaud's phenomenon]. Vasa (1990) 0.75
[Sonographic diagnosis of deep pelvic/leg venous thrombosis: is color-coded Duplex sonography "superfluous"?]. Ultraschall Med (1991) 0.75
[Vital capillary microscopy and with ophthalmoscope-detected findings in progressive systemic scleroderma]. Hautarzt (1987) 0.75
[Synthesis of 4-substituted 1-amidino- and 6-substituted 2-amidinonaphthyl derivatives with ketone and alcohol structure]. Pharmazie (1978) 0.75
[Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy]. Dtsch Med Wochenschr (1985) 0.75
[Capillary microscopic effect of naftidrofuryl in peripheral arterial occlusive disease]. Vasa Suppl (1988) 0.75
Is the capillary microscopic determination of the visible capillary length a diagnostic criterion in thromboangiitis obliterans? Vasa (1998) 0.75
[What is the advantage of color-coded duplex ultrasound of the vertebral arteries in comparison with i.a.-DSA?]. Vasa Suppl (1992) 0.75
[Definition and terminology of Raynaud's syndrome]. Dtsch Med Wochenschr (2008) 0.75
[What is the value of determining walking distance in peripheral arterial occlusive disease on the treadmill and in daily life? Prospective correlation study]. Med Klin (Munich) (1999) 0.75
[Synthesis of amidinobenzylaryl-, amidinobenzylalkyl- and amidinobenzylalkoxymethylketones]. Pharmazie (1976) 0.75
Laser-Doppler examinations in persons with healthy vasculature and in patients with peripheral arterial occlusive disease. Angiology (1986) 0.75
[Orofacial manifestations of progressive systemic scleroderma (PSS) and its effect on the stomatognathic system]. Quintessenz (1988) 0.75
[Drug therapy of arterial occlusive disease]. Internist (Berl) (2000) 0.75
[Effect of the degree of polymerization and particle size of the polymer powder on the processing and properties of denture synthetics]. Zahn Mund Kieferheilkd Zentralbl (1988) 0.75
Automatic endless polarization control with integrated-optical Ti:LiNbO(3) polarization transformers. Opt Lett (1988) 0.75
[Guideline for evaluating drugs in chronic venous insufficiency. 10 May 2000 edition]. Hautarzt (2001) 0.75
[Raynaud syndrome following timolol-containing eyedrops]. Fortschr Ophthalmol (1990) 0.75
[1st experience in the use of the suction-irrigation device with roller pump in the management of pyogenic bone infections]. Beitr Orthop Traumatol (1973) 0.75
[Synthesis of amidinophenylarylketones and alpha substituted amidinoacetophenones]. Pharmazie (1976) 0.75
[Vital capillary microscopic examination and transcutaneous pO2-measurements by intravenous prostaglandin E1 infusion]. Dtsch Med Wochenschr (1985) 0.75
[Long-term blood pressure measurements with i.v. prostaglandin E1 infusion]. Vasa Suppl (1989) 0.75
[Nicergoline and cerebral performance insufficiency. Observations in 1 year treatment controls]. Fortschr Med (1984) 0.75
Lithium niobate guided-wave network for a coherent receiver. Opt Lett (1989) 0.75
[Occlusion of finger arteries and thrombotic angiopathy of the retina during adjuvant tamoxifen therapy of a mammary carcinoma]. Dtsch Med Wochenschr (1997) 0.75
[Vital findings in capillary microscopy in collagen diseases]. Vasa Suppl (1991) 0.75
[Combined transcutaneous measurement of partial O2 and CO2 pressure as a diagnostic supplement in assessing the degree of severity of peripheral arterial occlusive disease]. Vasa Suppl (1991) 0.75
[Synthesis of 1-aryl-3-(amidinophenyl)-1-propanones and other compounds with a carbonyl group in the gamma position of the amidinophenyl radicals]. Pharmazie (1976) 0.75
[Synthetic inhibitors of serine proteinases. 9. The inhibition of tryspsin,plasmin and thrombin by amidinophenyl-, amidinobenzyl- and beta-(amidinophenyl)ethylarylketons]. Pharmazie (1976) 0.75
[Variability of transcutaneous p02 in repeated measurements in patients with peripheral arterial occlusive disease]. Vasa Suppl (1988) 0.75
[Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV]. J Mal Vasc (1987) 0.75
[Capillary microscopy findings in chronic polyarthritis and endangiitis obliterans]. Vasa Suppl (1987) 0.75
[Color-coded duplex sonography of lower leg arteries--imaging for classification of Fontaine stages]. Vasa Suppl (1991) 0.75
The carpal tunnel syndrome--a disease underlying Raynaud's phenomenon? Angiology (1988) 0.75
[Treatment of coxarthrosis with epsilon aminocaproic acid]. Beitr Orthop Traumatol (1972) 0.75